Sign inGet started

LaBella Nicholas A. Jr.

Insider CIK 1487698 · ZVSA Chief Scientific Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-1439,708— $039,708SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-1459,563— $059,563SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-1439,709— $039,709SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-1419,854— $019,854SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-1418,094— $018,094SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-1429,781— $029,781SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-1429,781— $029,781SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award2022-12-122022-12-1418,094— $018,094SEC↗